Endocrine-related Cancer

雜志介紹

Endocrine-related Cancer雜志介紹

《Endocrine-related Cancer》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱內(nèi)分泌相關(guān)癌癥，本刊主要出版、報道醫(yī)學-ENDOCRINOLOGY & METABOLISM領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為4.1，最新CiteScore 指數(shù)為7.8。

本刊近期中國學者發(fā)表的論文主要有：

• TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1/PI3K/AKT axis

  Author: Wang, Lidong; Tan, Hao; Huang, Yonglian; Guo, Mingyue; Dong, Yanxu; Liu, Chenxi; Zhao, Huai; Liu, Zhen

• The allelic regulation of tumor suppressor ADARB2 in papillary thyroid carcinoma

  Author: Li, Wenwen; Wang, Teng; Fu, Guobin; Xu, Yuan; Zhang, Nasha; Han, Linyu; Yang, Ming

• Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation

  Author: Hu, Chunyan; Wang, Manli; Hu, Miao; Ma, Shanshan; Yang, Bingmo; Xiao, Wei; Zhou, Qian; Zhou, Ming; Li, Zhong

• Cell diversity and immune infiltration in the parathyroid tumour microenvironment

  Author: Zhang, Xiang; Hu, Ya; Cui, Ming; Wang, Mengyi; Li, Xiaobin; Zhang, Yalu; Yang, Sen; Hua, Surong; Shen, Meiping; Liao, Quan

英文介紹

Endocrine-related Cancer雜志英文介紹

Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society.

Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.

Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.